XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Cross Currency Interest Rate Contract [Member]
Common Stock [Member]
Cross Currency Interest Rate Contract [Member]
Additional Paid-in Capital [Member]
Cross Currency Interest Rate Contract [Member]
Treasury Stock, Common [Member]
Cross Currency Interest Rate Contract [Member]
Retained Earnings [Member]
Cross Currency Interest Rate Contract [Member]
AOCI Attributable to Parent [Member]
Cross Currency Interest Rate Contract [Member]
Parent [Member]
Cross Currency Interest Rate Contract [Member]
Noncontrolling Interest [Member]
Cross Currency Interest Rate Contract [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2021                 56,056                
Balance at Dec. 31, 2021                   $ 56 $ 1,271,925 $ 0 $ 585,209 $ (2,191) $ 1,854,999 $ 143,462 $ 1,998,461
Stock-based compensation                   0 2,814 0 0 0 2,814 0 2,814
Exercise of stock-based awards by employees and directors (*) (in shares) [1]                 16                
Exercise of stock-based awards by employees and directors (*) [1]                   0 99 0 0 0 99 0 99
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (3,088) (3,088)
Cash dividend declared                   0 0 0 (6,727) 0 (6,727) 0 (6,727)
Net income                   0 0 0 18,430 0 18,430 4,105 22,535
Change in foreign currency translation adjustments                   0 0 0 0 (857) (857) (299) (1,156)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 3,902 3,902 0 3,902
Change in respect of derivative instruments designated for cash flow hedge $ 0 $ 0 $ 0 $ 0 $ (1,905) $ (1,905) $ 0 $ (1,905)                  
Other                   0 0 0 0 15 15 0 15
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                   0 0 0 0 (101) (101) 0 (101)
Net income                   0 0 0 18,430 0 18,430 4,105 22,535
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 3,902 3,902 0 3,902
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge 0 0 0 0 (1,905) (1,905) 0 (1,905)                  
Currency translation adjustment                   0 0 0 0 (857) (857) (299) (1,156)
Balance (in shares) at Mar. 31, 2022                 56,072                
Balance at Mar. 31, 2022                   56 1,274,838 0 596,912 (1,137) 1,870,669 144,180 2,014,849
Balance (in shares) at Dec. 31, 2021                 56,056                
Balance at Dec. 31, 2021                   56 1,271,925 0 585,209 (2,191) 1,854,999 143,462 1,998,461
Change in foreign currency translation adjustments                                 (4,615)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                                 5,445
Change in respect of derivative instruments designated for cash flow hedge                                 (4,000)
Other                                 30
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                 41
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                                 5,445
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge                                 (4,000)
Currency translation adjustment                                 (4,615)
Balance (in shares) at Jun. 30, 2022                 55,934                
Balance at Jun. 30, 2022                   56 1,253,242 (17,964) 601,441 (4,148) 1,832,627 146,667 1,979,294
Balance (in shares) at Mar. 31, 2022                 56,072                
Balance at Mar. 31, 2022                   56 1,274,838 0 596,912 (1,137) 1,870,669 144,180 2,014,849
Stock-based compensation                   0 2,999 0 0 0 2,999 0 2,999
Exercise of stock-based awards by employees and directors (*)                   0 (57) 0 0 0 (57) 0 (57)
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (140) (140)
Cash dividend declared                   0 0 0 (6,731) 0 (6,731) 0 (6,731)
Net income                   0 0 0 11,260 0 11,260 3,470 14,730
Change in foreign currency translation adjustments                   0 0 0 0 (2,616) (2,616) (843) (3,459)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 1,543 1,543 0 1,543
Change in respect of derivative instruments designated for cash flow hedge 0 0 0 0 (2,095) (2,095) 0 (2,095)                 (2,095)
Other                   0 0 0 0 15 15 0 15
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                   0 0 0 0 142 142 0 142
Purchase of treasury stock (in shares)                 (259)                
Purchase of treasury stock                   0 0 (17,964) 0 0 (17,964) 0 (17,964)
Purchase of capped call instruments                   0 (24,538) 0 0 0 (24,538) 0 (24,538)
Net income                   0 0 0 11,260 0 11,260 3,470 14,730
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 1,543 1,543 0 1,543
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge $ 0 $ 0 $ 0 $ 0 $ (2,095) $ (2,095) $ 0 $ (2,095)                 (2,095)
Currency translation adjustment                   0 0 0 0 (2,616) (2,616) (843) (3,459)
Balance (in shares) at Jun. 30, 2022                 55,934                
Balance at Jun. 30, 2022                   56 1,253,242 (17,964) 601,441 (4,148) 1,832,627 146,667 1,979,294
Balance (in shares) at Dec. 31, 2022                 56,096                
Balance at Dec. 31, 2022                   56 1,259,072 (17,964) 623,907 2,500 1,867,571 153,404 2,020,975
Stock-based compensation                   0 2,990 0 0 0 2,990 0 2,990
Exercise of stock-based awards by employees and directors (*)                   0 27 0 0 0 27 0 27
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (2,360) (2,360)
Cash dividend declared                   0 0 0 (6,732) 0 (6,732) 0 (6,732)
Net income                   0 0 0 29,029 0 29,029 4,235 33,264
Change in foreign currency translation adjustments                   0 0 0 0 (306) (306) (390) (696)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 (1,014) (1,014) 0 (1,014)
Change in respect of derivative instruments designated for cash flow hedge                   0 0 0 0 (5,403) (5,403) 0 (5,403)
Other                   0 0 0 0 14 14 0 14
Issuance of common stock (in shares)                 3,600                
Issuance of common stock                   4 297,117 0 0 0 297,121 0 297,121
Change in noncontrolling interest rights                   0 1,239 0 0 0 1,239 (2,396) (1,157)
Net income                   0 0 0 29,029 0 29,029 4,235 33,264
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 (1,014) (1,014) 0 (1,014)
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge                   0 0 0 0 (5,403) (5,403) 0 (5,403)
Currency translation adjustment                   0 0 0 0 (306) (306) (390) (696)
Balance (in shares) at Mar. 31, 2023                 59,696                
Balance at Mar. 31, 2023                   60 1,560,445 (17,964) 646,204 (4,209) 2,184,536 152,493 2,337,029
Balance (in shares) at Dec. 31, 2022                 56,096                
Balance at Dec. 31, 2022                   56 1,259,072 (17,964) 623,907 2,500 1,867,571 153,404 2,020,975
Change in foreign currency translation adjustments                                 (303)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                                 390
Change in respect of derivative instruments designated for cash flow hedge                                 (2,926)
Other                                 28
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                 0
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                                 390
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge                                 (2,926)
Currency translation adjustment                                 (303)
Balance (in shares) at Jun. 30, 2023                 60,236                
Balance at Jun. 30, 2023                   60 1,609,298 (17,964) 663,166 (170) 2,254,390 152,652 2,407,042
Balance (in shares) at Mar. 31, 2023                 59,696                
Balance at Mar. 31, 2023                   60 1,560,445 (17,964) 646,204 (4,209) 2,184,536 152,493 2,337,029
Stock-based compensation                   0 4,311 0 0 0 4,311 0 4,311
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (135) (135)
Cash dividend declared                   0 0 0 (7,229) 0 (7,229) 0 (7,229)
Net income                   0 0 0 24,191 0 24,191 45 24,236
Change in foreign currency translation adjustments                   0 0 0 0 144 144 249 393
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 1,404 1,404 0 1,404
Change in respect of derivative instruments designated for cash flow hedge                   0 0 0 0 2,477 2,477 0 2,477
Other                   0 0 0 0 14 14 0 14
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                 0
Issuance of common stock (in shares)                 540                
Issuance of common stock                   0 44,542 0 0 0 44,542 0 44,542
Net income                   0 0 0 24,191 0 24,191 45 24,236
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 1,404 1,404 0 1,404
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge                   0 0 0 0 2,477 2,477 0 2,477
Currency translation adjustment                   0 0 0 0 144 144 249 393
Balance (in shares) at Jun. 30, 2023                 60,236                
Balance at Jun. 30, 2023                   $ 60 $ 1,609,298 $ (17,964) $ 663,166 $ (170) $ 2,254,390 $ 152,652 $ 2,407,042
[1] Resulted in an amount lower than $1 thousand.